This compound is a purine-based pharmaceutical intermediate with a complex stereochemically defined cyclopenta[d][1,3]dioxolane core. It is primarily significant as a key building block in the manufacturing process of ticagrelor, an antiplatelet agent.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 376608-74-1
(3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol
Pharmaceutical impurity reference standard
2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate
Ticagrelor intermediate
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol
pharmaceutical intermediate
Ethyl (3R)-piperidine-3-carboxylate--hydrogen chloride (1/1)
Pharmaceutical intermediate for nipecotic acid derivatives
2,3-Dimethyl-4-nitropyridine 1-oxide
Pharmaceutical intermediate
1H-Pyrazole-4-carboxylic acid
pharmaceutical intermediate
2-[[(3aR,4S,6R,6aS)-6-[(5-amino-6-chloro-2-propylsulfanylpyrimidin-4-yl)amino]-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol
LODREYVWDWCAOB-RSLMWUCJSA-N
CCCSC1=NC(=C(C(=N1)Cl)N)N[C@@H]2C[C@@H]([C@@H]3[C@H]2OC(O3)(C)C)OCCO